Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab

Purpose. To evaluate antiangiogenic effect of local use of bevacizumab (anti-VEGF antibody) in patients with corneal neovascularization. Methods. Patients were divided into two groups. All patients suffered from some form of corneal neovascularization (NV). Patients in group A received 0.2–0.5 mL o...

Full description

Bibliographic Details
Main Authors: Krizova, Deli, Vokrojova, Magdalena, Liehneova, Katerina, Studeny, Pavel
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981012/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981012/

Similar Items